IMS Pharmaceutical Pricing & Reimbursement Concise Guide: UK

  • ID: 1408500
  • Report
  • Region: United Kingdom, Great Britain
  • 67 Pages
  • IMS Health
1 of 3
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Note: Product cover images may vary from those shown
2 of 3
1. Healthcare System
Facts & Figures
Market Indicators
Provision & Funding
Separate Administration
England
Scotland, Wales and Northern Ireland

2. Pricing
Prescription Drugs
2014 PPRS
Statutory Drug Price Controls
Rebates and Discounts
Generic Drugs
Branded
Unbranded
Reimbursement Prices
Hospital Drugs
Procurement
Average Selling Prices
OTC Drugs

3. Reimbursement
Admission to Reimbursement
England
Scotland
Wales
Northern Ireland
Patient Access Schemes
Early Access to Medicines
Negative List and Grey List
Reimbursement Categories
Reimbursement Prices
Drug Tariff
Hospital Reimbursement
Formularies
Funding
Changes in Reimbursement Status
England
Scotland
Wales
Northern Ireland
Changes in Reimbursement Prices
Price Increases
Price Modulation
Flexible Pricing
Overspending
Patient Access Schemes
Generics
Health Service Medicines Regulations
Other DH Proposals

4. Pharmacoeconomics
Pharmacoeconomic Requirements
England
Scotland
Wales
Northern Ireland
Proposed Reforms

5. Price Build Up
Wholesalers
Margins
Background
Retail Pharmacies
Margins
Dispensing Fees
Pharmacy Clawback
Background
Drug Classification
Dispensing Doctors
Sales Tax

6. Cost Containment
Industry Paybacks
PPRS
Health Service Medicines Regulations
Promotional Costs
Promotional Expenditure
Code of Conduct
Advertising
Patient Co-payments
Healthcare
Pharmaceuticals
Prescribing Controls
Prescribing Budgets
Prescribing Incentive Schemes
Prescribing Restrictions
Frameworks
Local Formularies
Prescribing Guidelines
Prescribing Data and Monitoring
E-prescribing
Prescribing Powers
Generics
Rx-to-OTC Switches
Switching Process
Parallel Trade

7. Future Developments
Outlook
EU Referendum
Impact of EU Withdrawal on the Pharmaceutical Sector
NHS Funding
Reform of NICE Appraisal Process
Statutory Drug Price Controls
Maximum Prices
Price Disclosure
Pharmacy Funding
Accelerated Access Review

8. Names & Addresses
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll